Cargando…
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
Autores principales: | Bojkova, Denisa, Rothenburger, Tamara, Ciesek, Sandra, Wass, Mark N., Michaelis, Martin, Cinatl, Jindrich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087166/ https://www.ncbi.nlm.nih.gov/pubmed/35538050 http://dx.doi.org/10.1038/s41421-022-00408-z |
Ejemplares similares
-
Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant of SARS-CoV-2 isolates
por: Bojkova, Denisa, et al.
Publicado: (2022) -
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
por: Bojkova, Denisa, et al.
Publicado: (2022) -
SARS-CoV-2 Variants Show Different Host Cell Proteome Profiles With Delayed Immune Response Activation in Omicron-Infected Cells
por: Metzler, Melinda, et al.
Publicado: (2023) -
Growth Factor Receptor Signaling Inhibition Prevents SARS-CoV-2 Replication
por: Klann, Kevin, et al.
Publicado: (2020) -
Differentially conserved amino acid positions may reflect differences in SARS-CoV-2 and SARS-CoV behaviour
por: Bojkova, Denisa, et al.
Publicado: (2021)